Guo ZC

No ORCID on file · 5 papers in corpus · active 2020-2022

Study types

  • article 4
  • other 1

Condition tags

  • adenomyosis 4
  • dysmenorrhea 2
  • endometriosis 1
  • endometrioma 1
article 2022
Journal of ovarian research ·doi:10.1186/s13048-022-00963-9

BACKGROUND: Brain-derived neurotrophic factor (BDNF) is a known regulator of the development and maintenance of chronic pain in various chronic disorders. Together with its high-affinity tyrosine kinase type B (TrKB) receptor, BDNF is exten…

other 2021
BioMed research international ·doi:10.1155/2021/8868700

Several theories on the origin of adenomyosis (ADS) have been proposed, of which the most widely accepted is the fundamental pathogenic role of uterine eutopic endometrium. Emerging evidence suggests that circular RNAs participate in the mu…

article 2021
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00444-8

Adenomyosis (ADS) is a commonly encountered benign gynecological disorder. Epithelial-mesenchymal transition (EMT) may serve a pivotal role in the pathogenesis of ADS. Talin1 has been identified to be implicated in multiple human carcinomas…

article 2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00756-7

Abstract Adenomyosis (ADS) is an estrogen-dependent gynecological disease with unspecified etiopathogenesis. Local hyperestrogenism may serve a key role in contributing to the origin of ADS. Talin1 is mostly identified to be overexpressed a…

article 2020
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20200226-00140

The levels of CXCL12 and CXCR4 in the endometrium and myometrium of adenomyosis are increased and positively correlated. The two chemokine may be involved in the development of adenomyosis.